ARCHIVES

In Brief: FDA Stops Imports Of Counterfeit Adriamychin; Rosenburg: NIH Pay 25-33% That Of Academia

This article is from The Cancer Letter archive.

Vol. 14 No. 17 | April 22, 1988

Download PDF Visit The Full Archive

Related Articles

Non-Profit Spent $1.3 Million On Consultants.

March 28, 2008

Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients.

April 9, 2010

Text of concept statement included in this 8-page issue.

July 16, 2004

NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive”

June 11, 2010

New Analyses of PCPT Give Stronger Justification Use of Finasteride To Prevent Prostate Cancer.

May 23, 2008

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012